Interpace Biosciences Inc (OTCQX US:IDXG)
| 3.00 Delayed Data As of Feb 26 |  -0.25 / -7.69%Today’s Change | 2.57 Today|||52-Week Range 10.03 | -4.46% Year-to-Date |
Latest IDXG News | Press Releases
No recent news for Interpace Biosciences Inc.
Today’s Trading
| Previous close | 3.25 |
| Today’s open | 3.55 |
| Day’s range | 3.00 - 3.68 |
| Volume | 380,743 |
| Average volume (3 months) | 199,828 |
| Market cap | $12.2M |
Data as of 02/26/2021
Growth & Valuation
| Earnings growth (last year) | -67.53% |
| Earnings growth (this year) | +8.44% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +10.61% |
| P/E ratio | -- |
| Price/Sales | 0.08 |
| Price/Book | -- |
Financials
| Next reporting date | March 31, 2021 |
| EPS forecast (this quarter) | -$1.32 |
| Annual revenue (last year) | $24.2M |
| Annual profit (last year) | -$26.7M |
| Net profit margin | -110.04% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Parsippany, New Jersey |
Forecasts
Chart unavailable
